Drug Profile
Teriparatide biosimilar - Primrose Bio
Alternative Names: BONSITY; Bonteo; Livogiva; PF-708; Qutavina; Teriparatide Injection; Teriparatide injection - Primrose BioLatest Information Update: 22 Sep 2023
Price :
$50
*
At a glance
- Originator Pfenex
- Developer Alvogen; NT Pharma; Primrose Bio
- Class Diagnostic agents; Osteoporosis therapies; Peptide hormones; Skin disorder therapies
- Mechanism of Action Parathyroid hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Male osteoporosis; Osteoporosis; Postmenopausal osteoporosis